Luigia Pace

Title: Luigia Pace: Innovator in Engineered Immune Cells

Introduction

Luigia Pace is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of immunology, particularly in the development of engineered immune cells. With a total of 4 patents, her work focuses on innovative therapies for cancer treatment.

Latest Patents

One of her latest patents involves immune cells defective for SUV39H1. This invention relates to an engineered immune cell that is specifically designed to inhibit the expression and/or activity of Suv39h1. The engineered immune cell also includes a genetically engineered antigen receptor that binds to a target antigen. This invention is particularly relevant for adoptive therapy, offering new avenues for cancer treatment.

Career Highlights

Luigia has worked with prestigious institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of immune cell engineering and its applications in therapeutic settings.

Collaborations

Throughout her career, Luigia has collaborated with notable colleagues, including Sebastian Amigorena and Eliane Piaggio. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Luigia Pace stands out as a leading inventor in the field of engineered immune cells, with her work paving the way for advancements in cancer therapy. Her contributions continue to inspire future innovations in immunology.